Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.91925 | 65 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.79934 | 64 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.75459 | 63 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.5901 | 61 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.70426 | 63 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.95363 | 65 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.21804 | 68 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.73069 | 62 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.72463 | 62 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.66707 | 62 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.76047 | 63 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.70544 | 62 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.09581 | 67 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.74874 | 63 |